Bavarian Nordic A/S: Bavarian Nordic Enters Agreement Valued up to USD 83 Million with the U.S. Department of Defense to Further Advance the Development of Equine Encephalitis Virus Vaccine
Total considerations of up to USD 83 million with the majority secured for Phase 2 development of the multivalent MVA-BN WEV vaccine candidate, in addition to options for Phase 3 preparatory work COPENHAGEN
New Jersey United States Paul Chaplin Graham Morrell Us Department Of Defense Us Centers For Disease
Source: finanznachrichten.de